Glucofit
Glucofit contains Metformin Hydrochloride, an oral biguanide antihyperglycemic agent. It works by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization.
Dosage by Body Weight
The standard starting dose of Glucofit is 500 mg twice daily or 850 mg once daily, administered with meals to reduce gastrointestinal side effects. Dosage increases should be made in increments of 500 mg weekly or 850 mg every 2 weeks, up to a maximum recommended dose of 2550 mg per day.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. |
Formulation
Purpose
Management of type 2 diabetes mellitus to improve glycemic control in adults and pediatric patients aged 10 years and older.
Generic Name
Metformin HydrochlorideScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.